Can antibiotic-resistant nosocomial infections be controlled?

Lancet Infectious Diseases

Volumn 1, Issue 1, 2001, Pages 38-45

  Farr, Barry M ^a   Salgado, Cassandra D ^a   Karchmer, Tobi B ^b   Sherertz, Robert J ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CROSS INFECTION; DISEASE TRANSMISSION; ECONOMICS; HUMAN; INFECTION CONTROL; METHODOLOGY; MICROBIOLOGY; PENICILLIN RESISTANCE; REVIEW; STANDARD; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 0035436913     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(01)00020-2     Document Type: Review

References (74)

1. Stosor V., Peterson L., Postelnick M., Noskin G. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med. 158:1998;522-527.
2. Cosgrove S, Perencevich E, Sakoulas G, Schwaber M, Karchmer A, Carmeli Y. Mortality related to methicillin-resistant bacteremia compared to methicillin-sensitive bacteremia. Abstracts of the 11th Annual Meeting of the Society for Healthcare Epidemiology of America, 2001; Toronto. p 60 (abstr 96).
3. Abramson M.A., Sexton D.J. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol. 20:1999;408-411.
4. Garner J.S. Hospital Infection Control Practices Advisory Committee. Guidelines for isolation precautions in hospitals. Infect Control Hosp Epidemiol. 17:1996;53-80.
5. Anonymous. Recommendations for preventing the spread of vancomycin resistance. MMWR Morb Mortal Wkly Rep. 44:1995;1-13.
6. NNIS System Report, data from January 1990-May 1999, Issued June 1999. Am J Infect Control. 27:1999;520-532.
7. Chambers H. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 7:2001;178-182.
8. Darwin C. On the origin of species by means of natural selection. 1859;J Murray Company, London.
9. Fridkin S.K., Steward C.D., Edwards J.R., et al. Surveillanceof antimicrobial use and antimicrobial resistance in UnitedStates hospitals: Project ICARE phase 2. Clin Infect Dis. 29:1999;245-252.
10. Byers K., Anglim A., Anneski C., et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol. 22:2001;140-147.
11. Troillet N., Carmeli Y., Samore M.H., et al. Carriage of methicillin-resistant Staphylococcus aureus at hospital admission. Infect Control Hosp Epidemiol. 19:1998;181-185.
12. Jernigan J.A., Titus M.G., Groschel D.H., Getchell-White S.I., Farr B.M. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol. 143:1996;496-504.
13. Price D., Sleigh J. Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. Lancet. 2:1970;1213-1215.
14. McGowan J.E.J.r. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis. 5:1983;1033-1048.
15. Jernigan J.A., Clemence M.A., Stott G.A., et al. Control of methicillin resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol. 16:1995;686-696.
16. Morris J.G., Shay D., Hebden J., et al. Enterococci resistant to multiple antimicrobial agents including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med. 123:1995;250-259.
17. Slaughter S., Hayden M.K., Nathan C., et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med. 125:1996;448-456.
18. Carmeli Y., Samore M.H., Huskins C. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Arch Intern Med. 159:1999;2461-2468.
19. Gruson D., Hilbert G., Vargas F., et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am J Resp Crit Care Med. 162:2000;837-843.
20. Kollef M., Vlasnik J., Sharpless L., Pasque C., Murphy D., Fraser V. Scheduled change of antibiotic classes. A strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med. 156:1997;1040-1048.
21. Hill A.B. A short textbook of medical statistics. 11th edn :1984;Hodder and Stoughton, London.
22. Quale J., Landman D., Saurina G., Atwood E., DiTore V., Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis. 23:1996;1020-1025.
23. Donskey C., Chowdhry T., Hecker M., et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. 343:2000;1925-1932.
24. Kunin C.M. Use of antibiotics: a brief exposition of the problem and some tentative solutions. Ann Intern Med. 79:1973;555-560.
25. Hirschman S., Meyers B., Bradbury K., Mehl B., Gendelman S., Kimelblatt B. Use of antimicrobial agents in a university teaching hospital. Arch Intern Med. 148:1988;2001-2007.
26. Gross R, Kinky D, Weiner M, Morgan A, Gibson G, Fishman N. A randomized controlled trial of a comprehensive antimicrobial management program. Abstracts of the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections; 2000; Atlanta. p 107 (abstr P-S2-04).
27. Pestotnik S., Classen D., Evans S., Burke J. Implementing antibiotic practice guidelines through computer-assisted decisionsupport: clinical and financial outcomes. Ann Intern Med. 124:1996;884-890.
28. Frank M.O., Batteiger B.E., Sorensen S.J., et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin Perform Qual Health Care. 5:1997;180-188.
29. Fukatsu K., Saito H., Matsuda T., Ikeda S., Furukawa S., Muto T. Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin-resistant Staphylococcus aureus and on the incidence of wound infection. Arch Surg. 132:1997;1320-1325.
30. Borgen K., Simonsen G., Sundsfjord A., Wasteson Y., Olsvik O., Kruse H. Continuing high prevalence of VanA-type vancomycin-resistant enterococci on Norwegian poultry farms three years after avoparcin was banned. J Appl Microbiol. 89:2000;478-485.
31. Salgado C, Sherertz R, Karchmer T, et al. Public health initiative to control MRSA and VRE in Virginia and North Carolina. Abstracts of the 11th Annual Meeting of the Society for Healthcare Epidemiology of America; 2001; Toronto. p 75 (abstr 164).
32. Schentag J., Hyatt J., Carr J., et al. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin Infect Dis. 26:1998;1204-1214.
33. Hartstein A.I., LeMonte A., Iwamoto P. DNA typing and control of methicillin-resistant Staphylococcus aureus at two affiliated hospitals. Infect Control Hosp Epidemiol. 18:1997;42-48.
34. Muto CA, Durbin LJ, Alexander CH, Karchmer TB, Farr BM. Frequency of community acquired MRSA at a university hospital. Abstracts of the Infectious Diseases Society of America Conference; 1997; San Francisco. p 135 (abstr 347).
35. Muto CA, Cage EG, Durbin LJ, Simonton BM, Farr BM.The utility of culturing patients on admission transferred from other health care facilities for methicillin-resistant Staphylococcus aureus (MRSA). Abstracts of the 9th Annual Meeting of theSociety for Healthcare Epidemiology of America; 1999; San Francisco. p 67 (abstr M33).
36. Haley R.W., Cushion N.B., Tenover F.C., et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis. 171:1995;614-624.
37. Thompson R.L., Cabezudo I., Wenzel R.P. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med. 97:1982;309-317.
38. Farr BM. Gastrointestinal carriage of VRE: importance of spread. 1st International Symposium on Resistant Gram-Positive Infections, Dec 5, 2000; San Antonio, TX, USA.
39. Goetz A.M., Rihs J.D., Wagener M.M., Muder R.R. Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: a 2-year survey. Am J Infect Control. 26:1998;558-562.
40. Bonten M.J., Hayden M.K., Nathan C., et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet. 348:1996;1615-1619.
41. Calfee D, Durbin L, Farr B. Evaluation of MRSA colonization among household contacts of patients undergoing MRSA eradication. Abstracts of the 11th Annual Meeting of the Society for Healthcare Epidemiology of America; 2001; Toronto. p 60 (abstr 99).
42. Shopsin B., Mathema B., Martinez J., et al. Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. Infect Control Hosp Epidemiol. 182:2000;359-362.
43. Sa-Leao R, Santos Sanches I, Alves C, Couto I, De Lancastre H. Low prevalence of carriage of methicillin resistant Staphylococcus aureus in healthy Portuguese populations. Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy: 2000; Toronto; p 69 (abstr 157).
44. Ofner-Agostini M, Simor A, Mulvey M, et al. Methicillin resistant Staphylococcus aureus (MRSA) within the Canadian Aboriginal community. Abstracts of the 11th Annual Meeting of the Society for Healthcare Epidemiology of America; 2001; Toronto. p 60 (abstr 98).
45. Zachary KC, Bayne PS, Morrison V, Ford DS, Silver LC, Hooper DC. Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci. Abstracts of the CDC 4th Decennial International Conference on Nosocomial and Healthcare-associated Infections; 2000; Atlanta; p 75 (abstr S-W4-02).
46. Montecalvo M., Shay D.K., Gedris C., et al. A semiquantitative analysis of the fecal flora of patients with vancomycin-resistant enterococci: colonized patients pose an infection control risk. Clin Infect Dis. 25:1997;929-930.
47. Boyce JM, Chenevert C. Isolation gowns prevent health care workers (HCWs) from contaminating their clothing, and possibly their hands, with methicillin-resistant Staphylococcus aureus (MRSA) and resistant enterococci. Abstracts of the 8th Annual Meeting of the Society for Healthcare Epidemiology of America; 1998; Orlando. p 52 (abstr S-74).
48. Boyce J.M., Potter-Bynoe G., Chenevert C., King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol. 18:1997;622-627.
49. Byers K.E., Durbin L.J., Simonton B.M., Anglim A.M., Adal K.A., Farr B.M. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 19:1998;261-264.
50. Boyce J., Opal S.M., Chow J.W., et al. Outbreak of multi-drug resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol. 32:1994;1148-1153.
51. Falk P.S., Winnike J., Woodmansee C., et al. Outbreak due to vancomycin-resistant enterococci (VRE) in a burn unit. Infect Control Hosp Epidemiol. 21:2000;575-582.
52. Neely A.N., Maley M.P. Survival of enterococci and staphylococci on hospital fabrics and plastics. J Clin Microbiol. 38:2000;724-726.
53. Smith T.L., Iwen P.C., Olson S.B., Rupp M.E. Environmental contamination with vancomycin-resistant enterococci in an outpatient setting. Infect Control Hosp Epidemiol. 19:1998;515-518.
54. Chaix C., Durand-Zaleski I., Alberti C., Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost benefit analysis in an intensive care unit. JAMA. 282:1999;1745-1751.
55. Jans B., Suetens C., Struelens M. Decreasing MRSA rates in Belgian hospitals: results from the national surveillance network after introduction of national guidelines. Infect Control Hosp Epidemiol. 21:2000;419.
56. Harbarth S., Martin Y., Rohner P., Henry N., Auckenthaler R., Pittet D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect. 46:2000;43-49.
57. Dembry L., Uzokwe K., Zervos M. Control of endemic glycopeptide-resistant enterococci. Infect Control Hosp Epidemiol. 17:1996;286-292.
58. Muto CA, Karchmer TB, Cage EG, Durbin LJ, Simonton BM, Farr BM. The utility of culturing roommates of patients with vancomycin-resistant enterococcus. Abstracts of the 8th Annual Meeting of the Society for Healthcare Epidemiology of America; 1998; Orlando; p 38 (abstr 76).
59. Calfee DP, Giannetta E, Durbin LJ, Farr BM. Control of vancomycin-resistant Enterococcus colonization among inpatients at a tertiary care facility. Abstracts of the CDC 4th Decennial International Conference in Conjunction with the 10th Annual Meeting of the Society for Healthcare Epidemiology of America; 2000; Atlanta. p 217 (abstr P-72-69).
60. Austin D.J., Bonten M.J.M., Weinstein R.A., Slaughter S., Anderson R.M. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci USA. 96:1999;6908-6913.
61. Ostrowsky B.E., Trick W.E., Sohn A.H., et al. Control of vancomycin-resistant Enterococcus in a region. N Engl J Med. 344:2001;1427-1433.
62. Quale J., Landman D., Atwood E., et al. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control. 24:1996;372-379.
63. Montecalvo M.A., de Lencastre H., Carraher M., et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 16:1995;680-685.
64. Frieden T.R., Munsiff S.S., Low D.E., et al. Emergence ofvancomycin-resistant enterococci in New York City. Lancet. 342:1993;76-79.
65. de Lencastre H., Brown A.E., Chung M., Armstrong D., Tomasz A. Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unitof a New York City hospital. Microbiol Drug Resistance. 5:1999;113-129.
66. Ostrowsky B., Steinberg J., Farr B., Sohn A., Sinkowitz-Cochran R., Jarvis W. Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients? Infect Control Hosp Epidemiol. 22:2001;116-119.
67. Calfee DP, Giannetta E, Farr BM. Effective control of VRE colonization using CDC recommendations for detectionand isolation. Abstracts of the 38th Annual Meeting of the Infectious Diseases Society of America; 2000; New Orleans. p 44 (abstr 21).
68. Reboli A., John J., Levkoff A. Epidemic methicillin-gentamicin-resistant Staphylococcus aureus in a neonatal intensive care unit. Am J Dis Child. 143:1989;34-39.
69. Pittet D., Hugonnet S., Harbarth S., et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet. 356:2000;1307-1312.
70. Larson E., Early E., Cloonan P., Sugrue S., Parides M. An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav Med. 26:2000;14-22.
71. Muto CA, Cage EG, Durbin LJ, Simonton BM, Farr BM. Cost effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Abstracts of the 9th Annual Meeting of the Society for Healthcare Epidemiology of America; 1999; San Francisco; p 44 (abstr 74).
72. Papia G., Louie M., Tralla A., Johnson C., Collins V., Simor A. Screening high risk patients for methicillin resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol. 20:1999;473-477.
73. Montecalvo M, Ulman J, Petrullo C, et al. The cost benefit of enhanced infection control strategies to prevent transmission of vancomycin resistant Enterococcus. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1997; Toronto. p 303 (abstr J84).
74. Monnet D. Control of antibiotic resistance in Europe. Plenary session. Global Conference on Antibiotic Resistance. Toronto, March, 1999.